One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v128.22.234.234
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 36 |
Affiliation: University of Rochester, Pharmacyclics (United States), AbbVie (United States), North Shore Hospital, University of California, San Diego, Royal Bournemouth Hospital, Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico, St James's University Hospital, Medical University of Lodz, Hospital de Sant Pau, Rabin Medical Center, King's College Hospital NHS Foundation Trust, Universitair Ziekenhuis Brussel, Ghent University Hospital, Ospedale Niguarda Ca' Granda, Jiangsu Province Hospital, Medical University of Silesia, The University of Texas MD Anderson Cancer Center, Foothills Medical Centre, Stanford University, Washington University in St. LouisUpdated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
